Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup
暂无分享,去创建一个
M. Kool | U. Schüller | A. Judkins | J. Cotter | P. Johann | M. Frühwald | M. Hasselblatt | W. Paulus | C. Haberler | L. Schweizer | Christian Thomas | K. Nemes | Matthias Dottermusch | J. Neumann | Francesca Zin | C. Thomas
[1] T. Gupta,et al. Atypical Teratoid/Rhabdoid Tumor: Revisiting Histomorphology and Immunohistochemistry With Analysis of Cyclin D1 Overexpression and MYC Amplification , 2020, International journal of surgical pathology.
[2] Ugljesa Djuric,et al. Unsupervised Machine Learning in Pathology: The Next Frontier. , 2020, Surgical pathology clinics.
[3] A. Huang,et al. Advancing biology based therapeutic approaches for atypical teratoid rhabdoid tumors. , 2020, Neuro-oncology.
[4] P. Northcott,et al. SWI/SNF complex heterogeneity relates with polyphenotypic differentiation, prognosis and immune response in rhabdoid tumors. , 2019, Neuro-oncology.
[5] M. Kool,et al. Tyrosinase immunohistochemistry can be employed for the diagnosis of atypical teratoid/rhabdoid tumours of the tyrosinase subgroup (ATRT‐TYR) , 2020, Neuropathology and applied neurobiology.
[6] M. Kool,et al. Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus , 2019, Neuro-oncology.
[7] S. Bens,et al. Age and DNA-methylation subgroup as potential independent risk factors for treatment stratification in children with Atypical Teratoid/Rhabdoid Tumors (ATRT). , 2019, Neuro-oncology.
[8] Steven J. M. Jones,et al. Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration , 2019, Cell reports.
[9] Till Acker,et al. DNA methylation-based classification of central nervous system tumours , 2018, Nature.
[10] David T. W. Jones,et al. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1‐deficient non‐rhabdoid tumor with favorable long‐term outcome , 2017, Brain pathology.
[11] Jie Ma,et al. Atypical teratoid/rhabdoid tumours: clinicopathological characteristics, prognostic factors and outcomes of 22 children from 2010 to 2015 in China. , 2016, Pathology.
[12] Mei Lu,et al. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. , 2016, Cancer cell.
[13] C. Roberts,et al. Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies. , 2016, Neuro-oncology.
[14] Roland Eils,et al. Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. , 2016, Cancer cell.
[15] M. Al-Hussaini,et al. Atypical teratoid/ rhabdoid tumor, an immunohistochemical study of potential diagnostic and prognostic markers , 2016, Neuropathology : official journal of the Japanese Society of Neuropathology.
[16] M. Bronner,et al. Establishing neural crest identity: a gene regulatory recipe , 2015, Development.
[17] Chris Allan,et al. OME Remote Objects (OMERO): a flexible, model-driven data management system for experimental biology , 2012, Nature Methods.
[18] R. Siebert,et al. Cribriform Neuroepithelial Tumor (CRINET): A Nonrhabdoid Ventricular Tumor With INI1 Loss and Relatively Favorable Prognosis , 2009, Journal of neuropathology and experimental neurology.
[19] T. Shaikh,et al. Genomic Analysis Using High-Density Single Nucleotide Polymorphism-Based Oligonucleotide Arrays and Multiplex Ligation-Dependent Probe Amplification Provides a Comprehensive Analysis of INI1/SMARCB1 in Malignant Rhabdoid Tumors , 2009, Clinical Cancer Research.
[20] H. Budka,et al. Immunohistochemical Analysis of INI1 Protein in Malignant Pediatric CNS Tumors: Lack of INI1 in Atypical Teratoid/Rhabdoid Tumors and in a Fraction of Primitive Neuroectodermal Tumors without Rhabdoid Phenotype , 2006, The American journal of surgical pathology.
[21] M. Rosenblum,et al. INI1 Protein Expression Distinguishes Atypical Teratoid/Rhabdoid Tumor from Choroid Plexus Carcinoma , 2005, Journal of neuropathology and experimental neurology.
[22] J. Biegel,et al. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood , 2005, Journal of Neuro-Oncology.
[23] J. Biegel,et al. Immunohistochemical Analysis of hSNF5/INI1 in Pediatric CNS Neoplasms , 2004, The American journal of surgical pathology.
[24] J. Biegel,et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. , 1999, Cancer research.
[25] J. Biegel,et al. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. , 1996, Journal of neurosurgery.
[26] D. Parham,et al. The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. , 1994, The American journal of surgical pathology.
[27] J. Beckwith,et al. Rhabdoid tumor. An entity or a phenotype? , 1989, Archives of pathology & laboratory medicine.